Recro Pharma Inc (NASDAQ:REPH)

1.65
Delayed Data
As of Jan 21
 0.00 / 0.00%
Today’s Change
1.38
Today|||52-Week Range
5.29
-3.51%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Recro Pharma Inc have a median target of 5.50, with a high estimate of 6.00 and a low estimate of 5.00. The median estimate represents a +233.33% increase from the last price of 1.65.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Recro Pharma Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.07
Sales
$21.4M
Reporting Date
Feb 24

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.76%
 
 
 
 
 
 
Growthannually 73.85%
 
 
 
 
 
 

Sales

Growthquarterly 17.41%
 
 
 
 
 
 
Growthannually 11.99%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.